Pharmacy-based Pre-exposure Prophylaxis

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Emory University
Study ID
NCT04393935
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Pharmacy Delivered PrEP Intervention — BEHAVIORAL
    Pharmacy client participants who are eligible and agree to the HIV test will be provided with a pre-packaged kit of a self-administered test for HIV and directed back to the private area of the pharmacy to perform their screening. Pharmacy client participants who test HIV negative will be provided with their results and be given a 30-day prescription for PrEP, culturally appropriate PrEP counseling and a follow-up appointment with a PrEP prescribing physician. Pharmacy client participants will be contacted after 3 months to determine whether they continued PrEP use.

Study Details

The proposed research will develop a culturally appropriate pharmacy pre-exposure prophylaxis (PrEP) delivery model for black men who have sex with men (BMSM) who live in high poverty, racial minority neighborhoods. Increasing access to PrEP through pharmacies has the potential to increase PrEP uptake among BMSM thereby reducing HIV incidence and racial inequities in HIV.

Key Dates

Start date
May 19, 2022
Status verified
Apr 2025
Primary completion
May 11, 2024
Completion
May 11, 2024

Study Design

Enrollment
49 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: Pharmacy Delivered PrEP Intervention
    Clients of the study pharmacies who participate in the intervention to receive PrEP through the pharmacy.

Primary Outcome Measure

Number of Participants Continuing PrEP [ Time Frame: Month 3 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Emory UniversityAtlantaGeorgia30322-

Find similar trials in Atlanta, GA

By condition
HIV
By specialty
Infectious disease
By research site
Emory University· Atlanta, GA

Related Studies